Sanara MedTech Inc

For the period ended Dec 31, 2023. Filed Mar 25, 2024.

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2023 · Filed Mar 25, 2024

SMTI$32.10+1.7%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Consolidated Statements of Changes in Shareholders’ Equity

Common Stock · Additional · Total
$0.001 par value · Paid-In · Accumulated · Noncontrolling · Shareholders’
	Shares	Amount	Capital	Deficit	Interest	Equity
Balance at December 31, 2021	7,676,662	$7,677	$45,867,768	$(15,235,044)	$(488,397)	$30,152,004
Issuance of common stock for acquisitions	457,424	457	11,128,053	-	(2,638)	11,125,872
Issuance of common stock options and warrants for acquisitions	-	-	4,612,645	-	-	4,612,645
Share-based compensation	173,959	174	3,790,643	-	-	3,790,817
Net settlement and retirement of equity-based awards	(8,088)	(8)	(185,122)	(222,216)	-	(407,346)
Distribution to noncontrolling interest member	-	-	-	-	(220,000)	(220,000)
Dissolution of investment	-	-	-	-	758,311	758,311
Net loss	-	-	-	(7,937,497)	(154,831)	(8,092,328)
Balance at December 31, 2022	8,299,957	$8,300	$65,213,987	$(23,394,757)	$(107,555)	$41,719,975
Share-based compensation	100,829	100	3,442,622	-	-	3,442,722
Net settlement and retirement of equity-based awards	34,501	35	203,031	(338,860)	-	(135,794)
Issuance of common stock for acquisitions	73,809	74	3,089,571	-	-	3,089,645
Issuance of common stock in equity offering	26,143	26	911,345	-	-	911,371
Net loss	-	-	-	(4,303,197)	(136,705)	(4,439,902)
Balance at December 31, 2023	8,535,239	$8,535	$72,860,556	$(28,036,814)	$(244,260)	$44,588,017

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.